Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry - Salvatori, R; Woodmansee, W W; Molitch, M (Pituitary, 2014)
et al.